Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Uremic Cardiomyopathy
NCT04500665Phase 2Recruiting
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2021
- Primary completion
- Jul 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in uremic cardiomyopathy (UCM), sponsored by Brigham and Women's Hospital. Started Nov 2021; status: recruiting.
02
Drugs
colchicine
03
Conditions
uremic cardiomyopathy (UCM)
Beyond the preview
Go deeper on NCT04500665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500665.